innovative ocular and cancer therapeutics
vasgen limited is an early-stage biotech company based in london uk developing novel monoclonal antibody therapeutics for unmet clinical needs in ophthalmology and cancer medicine. the company is developing a breakthrough antibody platform (abimp®) that generates selective inhibitors of therapeutically important but previously intractable metzincin protease targets.